HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

This pilot, multicenter, interventional study investigates the expression of HOXB7 and its associated molecular pathway in lung tissue and blood-derived exosomes from patients with pulmonary fibrosis (PF), including idiopathic pulmonary fibrosis (IPF). Using RNA sequencing (RNA-Seq) and proteomic analysis via mass spectrometry (MS), the study aims to identify tissue and circulating biomarkers associated with fibrosis progression. The study compares different biopsy techniques (surgical vs. transbronchial cryobiopsy) and also includes a control group of patients undergoing lung resection for non-fibrotic conditions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Adults aged 18 to 80 with clinical suspicion of pulmonary fibrosis

• Availability of fresh lung tissue from biopsy or lung explant

• Signed informed consent for research use of biological material and data

Locations
Other Locations
Italy
Azienda Ospedaliero Universitaria Policlinico di Modena
RECRUITING
Modena
Contact Information
Primary
Roberto Tonelli
rtonelli@unimore.it
+390594225934
Time Frame
Start Date: 2023-07-01
Estimated Completion Date: 2030-07-01
Participants
Target number of participants: 80
Treatments
Cases
Patients undergoing surgical lung biopsy/criobiopsy for clinical purpose in the diagnostic work-up of ILD.
Controls
Patients undergoing lung lobectomy for lung cancer suspicion.
Sponsors
Leads: University of Modena and Reggio Emilia

This content was sourced from clinicaltrials.gov